<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04035564</url>
  </required_header>
  <id_info>
    <org_study_id>01/03/18N01</org_study_id>
    <nct_id>NCT04035564</nct_id>
  </id_info>
  <brief_title>Early Sodium Intake in Preterm Newborns</brief_title>
  <official_title>Early Sodium Intake in Preterm Newborns; Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital del Niño &quot;Dr. Federico Gomez Santos&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital del Niño &quot;Dr. Federico Gomez Santos&quot;</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyponatremia is a common complication among preterm infants, renal losses of sodium
      contribute to the development of hyponatremia in preterm newborns. Sodium imbalances impact
      in newborns outcome. There is controversy about the time of initiation and the requirements
      of sodium in premature infants. Hypothesis: early (24 hours of life) sodium supplementation
      (5mEq/kg/day) prevents the develop of hyponatremia in preterm infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized controlled trial in infants less than 35 weeks gestation admitted
      to the Newborn Intensive Care Unit at Children Hospital in Saltillo Coahuila Mexico.

      Infants receive at 24 hours of life; sodium (5mEq/kg/day) versus less than 1mEq/kg/day.
      Weight, serum and urine sodium, serum chloride, serum and urine creatinine, serum chloride,
      bicarbonate and glucose are monitored daily during the first 3 days of life. Patients are
      assessed for hyponatremia, hypernatremia, weight change, sepsis, necrotizing enterocolitis
      and intraventricular hemorrhage.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 30, 2018</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">March 2, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hyponatremia</measure>
    <time_frame>72 hours</time_frame>
    <description>serum sodium &lt;130mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypernatremia</measure>
    <time_frame>72 hours</time_frame>
    <description>serum sodium &gt;150mEq/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>% Weight Change</measure>
    <time_frame>Initial weight (baseline) vs 72 hours</time_frame>
    <description>The difference between initial weight and 72hrs weight, expressed in percentage of birth weight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Serum Sodium</measure>
    <time_frame>Initial serum sodium (baseline) vs 72 hours</time_frame>
    <description>The difference between current serum sodium and initial serum sodium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight Change</measure>
    <time_frame>Initial weight (baseline) vs 72 hours</time_frame>
    <description>The difference between current weight and initial weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Late-onset Sepsis</measure>
    <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
    <description>Positive blood culture and/or 5 days of continuous antimicrobial therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Necrotizing Enterocolitis</measure>
    <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
    <description>Number of patients with Bell stage II or greater necrotizing enterocolitis
Bell's Staging:
Stage II A:
Gastrointestinal signs: Increasing gastric aspirates, mild abdominal distention, fecal occult blood, absent bowel sounds.
Systemic signs: Temperature instability, apnea, bradycardia, lethargy. Radiological findings: Intestinal dilatation, ileus, pneumatosis intestinalis.
Stage II B:
Gastrointestinal signs: As stage IIA plus abdominal tenderness. Systemic signs: As stage IIA plus metabolic acidosis and thrombocytopenia. Radiological findings: As stage IIA plus portal vein gas and ascites.
Stage III A:
Gastrointestinal signs: As stage IIB plus marked abdominal tenderness and generalised peritonitis.
Systemic signs: As stage IIB plus hypotension and severe apnea. Radiological findings: As stage IIB
Stage III B:
Gastrointestinal signs: As stage IIIA As stage IIIA As stage IIIA plus pneumoperitoneum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Intraventricular Hemorrhage</measure>
    <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
    <description>Bleeding into the brain´s ventricular system (intracranial ultrasound).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
    <description>Death during hospitalization.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Hyponatremia</condition>
  <condition>Premature</condition>
  <arm_group>
    <arm_group_label>Sodium &lt; 1mEq/kg/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium 5mEq/kg/day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium &lt; 1mEq/kg/day</intervention_name>
    <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
    <arm_group_label>Sodium &lt; 1mEq/kg/day</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium 5mEq/kg/day</intervention_name>
    <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
    <arm_group_label>Sodium 5mEq/kg/day</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants &lt;35 Weeks gestation

        Exclusion Criteria:

          -  Urinary malformations

          -  Congenital abdominal wall defect

          -  Intestinal atresia / obstruction

          -  Congenital heart defect
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Sanchez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric Nephrology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ben D Valdes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital del Niño Dr Federico Gomez Santos</name>
      <address>
        <city>Saltillo</city>
        <state>Coahuila</state>
        <zip>25280</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/548_GPC_ManejoliquidosyelectrolitosRNprematuros/GER_LiquidosEnPrematuro.pdf</url>
    <description>Mexico guidelines for fluids in preterm infants</description>
  </link>
  <reference>
    <citation>Wang J, Xu E, Xiao Y. Isotonic versus hypotonic maintenance IV fluids in hospitalized children: a meta-analysis. Pediatrics. 2014 Jan;133(1):105-13. doi: 10.1542/peds.2013-2041. Epub 2013 Dec 30. Review.</citation>
    <PMID>24379232</PMID>
  </reference>
  <reference>
    <citation>Bhatia J. Fluid and electrolyte management in the very low birth weight neonate. J Perinatol. 2006 May;26 Suppl 1:S19-21. Review.</citation>
    <PMID>16625217</PMID>
  </reference>
  <reference>
    <citation>Moritz ML, Ayus JC. Hyponatremia in preterm neonates: not a benign condition. Pediatrics. 2009 Nov;124(5):e1014-6. doi: 10.1542/peds.2009-1869. Epub 2009 Oct 26.</citation>
    <PMID>19858147</PMID>
  </reference>
  <reference>
    <citation>Balasubramanian K, Kumar P, Saini SS, Attri SV, Dutta S. Isotonic versus hypotonic fluid supplementation in term neonates with severe hyperbilirubinemia - a double-blind, randomized, controlled trial. Acta Paediatr. 2012 Mar;101(3):236-41. doi: 10.1111/j.1651-2227.2011.02508.x. Epub 2011 Nov 19.</citation>
    <PMID>22040311</PMID>
  </reference>
  <reference>
    <citation>Al-Dahhan J, Haycock GB, Nichol B, Chantler C, Stimmler L. Sodium homeostasis in term and preterm neonates. III. Effect of salt supplementation. Arch Dis Child. 1984 Oct;59(10):945-50.</citation>
    <PMID>6497431</PMID>
  </reference>
  <reference>
    <citation>Gawlowski Z, Aladangady N, Coen PG. Hypernatraemia in preterm infants born at less than 27 weeks gestation. J Paediatr Child Health. 2006 Dec;42(12):771-4.</citation>
    <PMID>17096711</PMID>
  </reference>
  <reference>
    <citation>Lönnqvist PA. III. Fluid management in association with neonatal surgery: even tiny guys need their salt. Br J Anaesth. 2014 Mar;112(3):404-6. doi: 10.1093/bja/aet436. Epub 2013 Dec 23.</citation>
    <PMID>24368557</PMID>
  </reference>
  <reference>
    <citation>Oh W. Fluid and electrolyte management of very low birth weight infants. Pediatr Neonatol. 2012 Dec;53(6):329-33. doi: 10.1016/j.pedneo.2012.08.010. Epub 2012 Oct 12. Review.</citation>
    <PMID>23276435</PMID>
  </reference>
  <reference>
    <citation>Hartnoll G, Bétrémieux P, Modi N. Randomised controlled trial of postnatal sodium supplementation on oxygen dependency and body weight in 25-30 week gestational age infants. Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F19-23.</citation>
    <PMID>10634836</PMID>
  </reference>
  <reference>
    <citation>Hartnoll G, Bétrémieux P, Modi N. Randomised controlled trial of postnatal sodium supplementation on body composition in 25 to 30 week gestational age infants. Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F24-8.</citation>
    <PMID>10634837</PMID>
  </reference>
  <reference>
    <citation>Lorenz JM, Kleinman LI, Kotagal UR, Reller MD. Water balance in very low-birth-weight infants: relationship to water and sodium intake and effect on outcome. J Pediatr. 1982 Sep;101(3):423-32.</citation>
    <PMID>7050331</PMID>
  </reference>
  <reference>
    <citation>Costarino AT Jr, Gruskay JA, Corcoran L, Polin RA, Baumgart S. Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: a randomized, blind therapeutic trial. J Pediatr. 1992 Jan;120(1):99-106.</citation>
    <PMID>1731034</PMID>
  </reference>
  <reference>
    <citation>Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R; Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005 Nov;41 Suppl 2:S1-87.</citation>
    <PMID>16254497</PMID>
  </reference>
  <reference>
    <citation>Bolisetty S, Osborn D, Sinn J, Lui K; Australasian Neonatal Parenteral Nutrition Consensus Group. Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012. BMC Pediatr. 2014 Feb 18;14:48. doi: 10.1186/1471-2431-14-48.</citation>
    <PMID>24548745</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 23, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2019</study_first_posted>
  <results_first_submitted>March 25, 2020</results_first_submitted>
  <results_first_submitted_qc>March 25, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 8, 2020</results_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital del Niño &quot;Dr. Federico Gomez Santos&quot;</investigator_affiliation>
    <investigator_full_name>csanchezg</investigator_full_name>
    <investigator_title>Pediatric Nephrology</investigator_title>
  </responsible_party>
  <keyword>Preterm infant</keyword>
  <keyword>Sodium</keyword>
  <keyword>Hyponatremia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 15, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04035564/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period: March 30, 2018 - February 28, 2020
Inclusion Criteria:
Preterm infants &lt;35 Weeks gestation, less than 24 hrs of age.
Exclusion Criteria:
Urinary malformations
Congenital abdominal wall defect
Intestinal atresia / obstruction
Congenital heart defect
Location: Neonatology (Pediatric Hospital)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Sodium &lt; 1mEq/kg/Day</title>
          <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
        </group>
        <group group_id="P2">
          <title>Sodium 5mEq/kg/Day</title>
          <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No laboratory available</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Guardian declined consent</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sodium &lt; 1mEq/kg/Day</title>
          <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
        </group>
        <group group_id="B2">
          <title>Sodium 5mEq/kg/Day</title>
          <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Gestational Age (Weeks)</description>
          <units>Weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="2.067"/>
                    <measurement group_id="B2" value="32.05" spread="2.460"/>
                    <measurement group_id="B3" value="32.02" spread="2.225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Mexico</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Birth weight</title>
          <units>Grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1551.08" spread="447.73"/>
                    <measurement group_id="B2" value="1609.47" spread="394.92"/>
                    <measurement group_id="B3" value="1577.50" spread="420.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Length of hospital stay</title>
          <population>Only patients who were discharged to home were included.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="14"/>
                    <count group_id="B3" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.43" spread="16.28"/>
                    <measurement group_id="B2" value="24.07" spread="18.39"/>
                    <measurement group_id="B3" value="26.40" spread="17.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hyponatremia</title>
        <description>serum sodium &lt;130mEq/L</description>
        <time_frame>72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Hyponatremia</title>
          <description>serum sodium &lt;130mEq/L</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.71</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.20</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.026</ci_lower_limit>
            <ci_upper_limit>1.533</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hypernatremia</title>
        <description>serum sodium &gt;150mEq/L</description>
        <time_frame>72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Hypernatremia</title>
          <description>serum sodium &gt;150mEq/L</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.89</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.21</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.081</ci_lower_limit>
            <ci_upper_limit>18.09</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>% Weight Change</title>
        <description>The difference between initial weight and 72hrs weight, expressed in percentage of birth weight.</description>
        <time_frame>Initial weight (baseline) vs 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>% Weight Change</title>
          <description>The difference between initial weight and 72hrs weight, expressed in percentage of birth weight.</description>
          <units>% of birth weight</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.206" spread="4.305"/>
                    <measurement group_id="O2" value="-6.345" spread="3.951"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.032</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.861</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.286</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.461</ci_lower_limit>
            <ci_upper_limit>-0.261</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.032</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.86</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.286</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.461</ci_lower_limit>
            <ci_upper_limit>-0.261</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Serum Sodium</title>
        <description>The difference between current serum sodium and initial serum sodium</description>
        <time_frame>Initial serum sodium (baseline) vs 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Serum Sodium</title>
          <description>The difference between current serum sodium and initial serum sodium</description>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.921" spread="7.70"/>
                    <measurement group_id="O2" value="5.71" spread="7.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.107</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-3.788</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.299</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.43</ci_lower_limit>
            <ci_upper_limit>0.858</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.107</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-3.78</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.299</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.43</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight Change</title>
        <description>The difference between current weight and initial weight</description>
        <time_frame>Initial weight (baseline) vs 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Change</title>
          <description>The difference between current weight and initial weight</description>
          <units>Grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-135.43" spread="57.46"/>
                    <measurement group_id="O2" value="-96.05" spread="53.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.028</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-39.38</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>17.22</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-74.18</ci_lower_limit>
            <ci_upper_limit>-4.57</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.028</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-39.38</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>17.22</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-74.18</ci_lower_limit>
            <ci_upper_limit>-4.57</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Late-onset Sepsis</title>
        <description>Positive blood culture and/or 5 days of continuous antimicrobial therapy</description>
        <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Late-onset Sepsis</title>
          <description>Positive blood culture and/or 5 days of continuous antimicrobial therapy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.55</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.75</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.296</ci_lower_limit>
            <ci_upper_limit>1.932</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Necrotizing Enterocolitis</title>
        <description>Number of patients with Bell stage II or greater necrotizing enterocolitis
Bell's Staging:
Stage II A:
Gastrointestinal signs: Increasing gastric aspirates, mild abdominal distention, fecal occult blood, absent bowel sounds.
Systemic signs: Temperature instability, apnea, bradycardia, lethargy. Radiological findings: Intestinal dilatation, ileus, pneumatosis intestinalis.
Stage II B:
Gastrointestinal signs: As stage IIA plus abdominal tenderness. Systemic signs: As stage IIA plus metabolic acidosis and thrombocytopenia. Radiological findings: As stage IIA plus portal vein gas and ascites.
Stage III A:
Gastrointestinal signs: As stage IIB plus marked abdominal tenderness and generalised peritonitis.
Systemic signs: As stage IIB plus hypotension and severe apnea. Radiological findings: As stage IIB
Stage III B:
Gastrointestinal signs: As stage IIIA As stage IIIA As stage IIIA plus pneumoperitoneum</description>
        <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Necrotizing Enterocolitis</title>
          <description>Number of patients with Bell stage II or greater necrotizing enterocolitis
Bell's Staging:
Stage II A:
Gastrointestinal signs: Increasing gastric aspirates, mild abdominal distention, fecal occult blood, absent bowel sounds.
Systemic signs: Temperature instability, apnea, bradycardia, lethargy. Radiological findings: Intestinal dilatation, ileus, pneumatosis intestinalis.
Stage II B:
Gastrointestinal signs: As stage IIA plus abdominal tenderness. Systemic signs: As stage IIA plus metabolic acidosis and thrombocytopenia. Radiological findings: As stage IIA plus portal vein gas and ascites.
Stage III A:
Gastrointestinal signs: As stage IIB plus marked abdominal tenderness and generalised peritonitis.
Systemic signs: As stage IIB plus hypotension and severe apnea. Radiological findings: As stage IIB
Stage III B:
Gastrointestinal signs: As stage IIIA As stage IIIA As stage IIIA plus pneumoperitoneum</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.84</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.09</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.169</ci_lower_limit>
            <ci_upper_limit>7.096</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Intraventricular Hemorrhage</title>
        <description>Bleeding into the brain´s ventricular system (intracranial ultrasound).</description>
        <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Intraventricular Hemorrhage</title>
          <description>Bleeding into the brain´s ventricular system (intracranial ultrasound).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.70</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.266</ci_lower_limit>
            <ci_upper_limit>2.448</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality</title>
        <description>Death during hospitalization.</description>
        <time_frame>Patients will be followed during hospitalization, an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium &lt; 1mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
          </group>
          <group group_id="O2">
            <title>Sodium 5mEq/kg/Day</title>
            <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <description>Death during hospitalization.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.33</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.57</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.62</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Through hospitalization stay, an expected average of 3 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sodium &lt; 1mEq/kg/Day</title>
          <description>Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life one
Sodium &lt; 1mEq/kg/day: Sodium administration enteral and/or parenteral less than 1mEq/kg/day started on day of life 1</description>
        </group>
        <group group_id="E2">
          <title>Sodium 5mEq/kg/Day</title>
          <description>Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life one
Sodium 5mEq/kg/day: Sodium administration enteral and/or parenteral 5mEq/kg/day started on day of life 1</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small numbers of subjects analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Carlos Sanchez</name_or_title>
      <organization>Hospital del Niño de Saltillo &quot;Dr. Federico Gomez Santos&quot;</organization>
      <phone>+528441757244</phone>
      <email>sanchez.carlos8516@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

